TWINJECT 0.3 Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which patents cover Twinject 0.3, and when can generic versions of Twinject 0.3 launch?
Twinject 0.3 is a drug marketed by Impax and is included in one NDA. There are two patents protecting this drug.
This drug has forty-three patent family members in fifteen countries.
The generic ingredient in TWINJECT 0.3 is epinephrine. There are twenty-one drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the epinephrine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Twinject 0.3
A generic version of TWINJECT 0.3 was approved as epinephrine by BELCHER on July 29th, 2014.
Summary for TWINJECT 0.3
International Patents: | 43 |
US Patents: | 2 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 78 |
Clinical Trials: | 1 |
Patent Applications: | 4,594 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TWINJECT 0.3 at DailyMed |

Recent Clinical Trials for TWINJECT 0.3
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Arthroplasty Foundation, Inc. | Phase 4 |
University of Louisville | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for TWINJECT 0.3
US Patents and Regulatory Information for TWINJECT 0.3
TWINJECT 0.3 is protected by two US patents.
Patents protecting TWINJECT 0.3
Medicine injection devices and methods
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Method and apparatus for delivering epinephrine
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Impax | TWINJECT 0.3 | epinephrine | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | 020800-001 | May 30, 2003 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
Impax | TWINJECT 0.3 | epinephrine | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | 020800-001 | May 30, 2003 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for TWINJECT 0.3
See the table below for patents covering TWINJECT 0.3 around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Spain | 2173117 | See Plans and Pricing | |
Russian Federation | 2131748 | AUTOMATIC OR MANUAL DEVICE FOR INJECTIONS OF LIQUID MEDICINAL AGENT | See Plans and Pricing |
World Intellectual Property Organization (WIPO) | 9531235 | See Plans and Pricing | |
European Patent Office | 3263161 | ENSEMBLE AIGUILLE D'INJECTION (INJECTION NEEDLE ASSEMBLY) | See Plans and Pricing |
South Africa | 200704516 | Medicine injection devices and methods | See Plans and Pricing |
>Country | >Patent Number | >Title | >Estimated Expiration |